We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Endometrial Ablation for Abnormal Uterine Bleeding Associated with High Risk of Hysterectomy

By HospiMedica International staff writers
Posted on 02 Oct 2024

Endometrial ablation (EA) is a minimally invasive procedure used to treat abnormal uterine bleeding (AUB) and is often presented as an alternative to hysterectomy. More...

While EA is generally considered safe with low complication rates, less is understood about the likelihood of patients needing further surgical intervention after the procedure. A recent study has revealed that 29% of individuals who undergo EA will eventually require a hysterectomy to remove the entire uterus within 15 years.

A research group comprising investigators from ICES (Toronto, ON, Canada) conducted an analysis of 76,446 patients over a 15-year period to investigate the need for surgical interventions after an initial EA. The study, published in Facts, Views & Vision in ObGyn, focused on patients who underwent their first EA between 2002 and 2017. The study showed that 22% of these patients required further surgical procedures following their EA. Within the first year, 5% of women proceeded to have a hysterectomy. This rate increased to 17% at five years, 23% at 10 years, and 29% at 15 years. Notably, the rate showed no signs of leveling off even at the 15-year mark. The likelihood of needing a subsequent hysterectomy was higher among younger individuals, those with more complex diagnoses, or those who had previously undergone abdominal surgeries like tubal ligation.

The high percentage of women who ultimately progressed to hysterectomy raises concerns and suggests that EA may be more effective as a short-term solution to improve symptoms, rather than a definitive treatment to prevent hysterectomy, according to the researchers. Additionally, the study found a correlation between surgeon experience and the future risk of surgery following EA. For each additional year of the surgeon's experience (with age used as a proxy), the likelihood of a hysterectomy decreased by 3%. The researchers highlight the potential benefits of combination treatments, such as intrauterine devices (IUDs) or hormone replacement therapies, which may extend the effectiveness of EA and reduce the need for further surgeries, particularly if patients approach menopause. However, they note that more research is needed to explore these treatment options further.

“These results provide valuable information to care providers, who can counsel their patients about more realistic outcomes of endometrial ablation, and the potential need for a future hysterectomy,” said lead author Dr. Jacob McGee, an adjunct scientist at ICES Western.


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.